Acute myeloid leukemia trials in Hong Kong

4 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

  Where

  Hong Kong

  Age

  18 years and over

  People

  600 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT06852222 · EU 2024-520154-38-00
• Phase 2Not yet taking people in Hong Kong
  Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML

  Where

  Hong Kong

  Age

  18 years and over

  People

  45

  Run by

  The University of Hong Kong

  See details and how to joinNCT07493408
• Phase 2Taking people
  Oral-ATO for TP53-mutated Myeloid Malignancies

  Where

  Hong Kong

  Age

  18 years and over

  People

  30

  Run by

  The University of Hong Kong

  See details and how to joinNCT06778187
• Phase 3Taking people
  Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML

  Where

  Hong Kong

  Age

  Up to 18 years

  People

  170 worldwide

  Run by

  Vastra Gotaland Region

  See details and how to joinNCT05477589